<?xml version="1.0" encoding="UTF-8"?>
<p id="par0085">Despite these promising results, there is some controversy about the generalized use of antimalarial drugs in the treatment of COVID-19.
 <xref rid="bib0205" ref-type="bibr">
  <sup>18</sup>
 </xref> All drugs need to meet efficacy and safety criteria in order to standardize their use in humans. Although the evidence regarding efficacy, which is being evaluated in this article, is still scarce, the results of several ongoing clinical trials are expected to be published soon, which will shed light on the relevance of replacing current treatments with this new alternative. The rapid development of evidence requires that the conclusions of this editorial should be taken with caution.
</p>
